会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明公开
    • PARTICULATE MEDICINAL COMPOSITION
    • MEDIZINISCHE PARTIKELZUSAMMENSETZUNG
    • EP2415463A1
    • 2012-02-08
    • EP11711242.5
    • 2011-02-14
    • NanoCarrier Co., Ltd.
    • ISHII, AtsushiKATO, Yasuki
    • A61K9/107A61K9/19A61K47/24A61K47/34
    • A61K9/1075A61K9/16A61K9/19A61K31/7084A61K31/713A61K47/24A61K47/34
    • The present invention provides a particulate pharmaceutical composition which has improved drug encapsulation stability and is suitable for a drug delivery system. The particulate pharmaceutical composition 1 contains: a plurality of block copolymer unit 2 arranged radially, each of which has a hydrophobic polymer-chain segment 2b, which is arranged radially inside, and a hydrophilic polymer-chain segment 2a, which is arranged radially outside; a drug 4, which includes a biomacromolecule; and a charged lipid 3, which has an electrical charge opposite to that of the drug 4; wherein the charged lipid 3 is being attracted to the hydrophobic polymer-chain segment 2b, and the drug 3 is positioned radially inside the hydrophobic polymer-chain segment 2b. The pharmaceutical composition 1 can effectively prevent the drug 4 from disengaging from the particle.
    • 本发明提供了具有改善的药物包封稳定性并且适合于药物递送系统的颗粒药物组合物。 颗粒状药物组合物1含有多个径向配置的嵌段共聚物单元2,每个嵌段共聚物单元2具有位于径向内侧的疏水性聚合物链段2b和位于径向外侧的亲水性聚合物链段2a; 包括生物大分子的药物4; 和带电荷的脂质3,其具有与药物4相反的电荷; 其中带电脂质3被吸引到疏水聚合物链段2b,并且药物3位于疏水性聚合物链段2b的径向内部。 药物组合物1可以有效地防止药物4与粒子分离。